Venclyxto (venetoclax) film-coated tablets- all strengths
The SPC has been updated to reflect licence extension covering use in combination with a hypomethylating agent for the treatment of adult patients with newly diagnosed acute myeloid who are ineligible for intensive chemotherapy.
Source:
electronic Medicines compendium